These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33991535)

  • 21. Targeted drug delivery to chemoresistant cells: folic acid derivatization of FdUMP[10] enhances cytotoxicity toward 5-FU-resistant human colorectal tumor cells.
    Liu J; Kolar C; Lawson TA; Gmeiner WH
    J Org Chem; 2001 Aug; 66(17):5655-63. PubMed ID: 11511236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of surface functionalized hydroxyapatite nanoparticles for enhanced specificity towards tumor cells.
    Verma G; Shetake NG; Pandrekar S; Pandey BN; Hassan PA; Priyadarsini KI
    Eur J Pharm Sci; 2020 Mar; 144():105206. PubMed ID: 31870813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adenovirus and Oxaliplatin cooperate as agnostic sensitizers for immunogenic cell death in colorectal carcinoma.
    Jessup JM; Kabbout M; Korokhov N; Joun A; Tollefson AE; Wold WSM; Mattoo AR
    Hum Vaccin Immunother; 2020 Mar; 16(3):636-644. PubMed ID: 31584324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Second-line chemotherapy with weekly oxaliplatin and high-dose 5-fluorouracil with folinic acid in metastatic colorectal carcinoma: a Hellenic Cooperative Oncology Group (HeCOG) phase II feasibility study.
    Janinis J; Papakostas P; Samelis G; Skarlos D; Papagianopoulos P; Fountzilas G
    Ann Oncol; 2000 Feb; 11(2):163-7. PubMed ID: 10761750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor tropic delivery of FU.FA@NSs using mesenchymal stem cells for synergistic chemo-photodynamic therapy of colorectal cancer.
    Jahedi M; Meshkini A
    Colloids Surf B Biointerfaces; 2023 Jun; 226():113333. PubMed ID: 37141773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In Vivo Antitumor Activity of Folate-Conjugated Cholic Acid-Polyethylenimine Micelles for the Codelivery of Doxorubicin and siRNA to Colorectal Adenocarcinomas.
    Amjad MW; Amin MC; Katas H; Butt AM; Kesharwani P; Iyer AK
    Mol Pharm; 2015 Dec; 12(12):4247-58. PubMed ID: 26567518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation.
    Hind D; Tappenden P; Tumur I; Eggington S; Sutcliffe P; Ryan A
    Health Technol Assess; 2008 May; 12(15):iii-ix, xi-162. PubMed ID: 18462574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Annexin A3 depletion overcomes resistance to oxaliplatin in colorectal cancer via the MAPK signaling pathway.
    Xu R; Yin J; Zhang Y; Zhang S
    J Cell Biochem; 2019 Sep; 120(9):14585-14593. PubMed ID: 30998268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyaluronic acid functionalized citric acid dendrimer/UiO-66-COOH as a stable and biocompatible platform for daunorubicin delivery.
    Pooresmaeil M; Namazi H
    Int J Biol Macromol; 2024 May; 268(Pt 1):131590. PubMed ID: 38621563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Folate-functionalized nanoparticles for controlled 5-Fluorouracil delivery.
    Zhang Y; Li J; Lang M; Tang X; Li L; Shen X
    J Colloid Interface Sci; 2011 Feb; 354(1):202-9. PubMed ID: 21094493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mission impossible for cellular internalization: When porphyrin alliance with UiO-66-NH
    Ahmadi S; Jajarmi V; Ashrafizadeh M; Zarrabi A; Haponiuk JT; Saeb MR; Lima EC; Rabiee M; Rabiee N
    J Hazard Mater; 2022 Aug; 436():129259. PubMed ID: 35739778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanistic Investigation into the Selective Anticancer Cytotoxicity and Immune System Response of Surface-Functionalized, Dichloroacetate-Loaded, UiO-66 Nanoparticles.
    Abánades Lázaro I; Haddad S; Rodrigo-Muñoz JM; Orellana-Tavra C; Del Pozo V; Fairen-Jimenez D; Forgan RS
    ACS Appl Mater Interfaces; 2018 Feb; 10(6):5255-5268. PubMed ID: 29356507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization and evaluation of a folic acid receptor-targeted cyclodextrin complex as an anticancer drug delivery system.
    Xu J; Xu B; Shou D; Qin F; Xu Y; Hu Y
    Eur J Pharm Sci; 2016 Feb; 83():132-42. PubMed ID: 26577995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel 5-Fluorouracil targeted delivery to colon cancer using folic acid conjugated liposomes.
    Handali S; Moghimipour E; Rezaei M; Ramezani Z; Kouchak M; Amini M; Angali KA; Saremy S; Dorkoosh FA
    Biomed Pharmacother; 2018 Dec; 108():1259-1273. PubMed ID: 30372827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Luminescent Amine-Functionalized Metal-Organic Framework Conjugated with Folic Acid as a Targeted Biocompatible pH-Responsive Nanocarrier for Apoptosis Induction in Breast Cancer Cells.
    Abazari R; Ataei F; Morsali A; Slawin AMZ; L Carpenter-Warren C
    ACS Appl Mater Interfaces; 2019 Dec; 11(49):45442-45454. PubMed ID: 31718155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxaliplatin added to 5-fluorouracil-based therapy (5-FU +/- FA) in the treatment of 5-FU-pretreated patients with advanced colorectal carcinoma (ACRC): results from the European compassionate-use program.
    Brienza S; Bensmaïne MA; Soulié P; Louvet C; Gamelin E; François E; Ducreux M; Marty M; André T; de Braud F; Bleiberg H; Ségal V; Itzhaki M; Cvitkovic E
    Ann Oncol; 1999 Nov; 10(11):1311-6. PubMed ID: 10631458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple nanoemulsion system for an oral combinational delivery of oxaliplatin and 5-fluorouracil: preparation and in vivo evaluation.
    Pangeni R; Choi SW; Jeon OC; Byun Y; Park JW
    Int J Nanomedicine; 2016; 11():6379-6399. PubMed ID: 27942212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 9-NC-loaded folate-conjugated polymer micelles as tumor targeted drug delivery system: preparation and evaluation in vitro.
    Han X; Liu J; Liu M; Xie C; Zhan C; Gu B; Liu Y; Feng L; Lu W
    Int J Pharm; 2009 May; 372(1-2):125-31. PubMed ID: 19166923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Folate receptor-targeted multimodal polymersomes for delivery of quantum dots and doxorubicin to breast adenocarcinoma: In vitro and in vivo evaluation.
    Alibolandi M; Abnous K; Sadeghi F; Hosseinkhani H; Ramezani M; Hadizadeh F
    Int J Pharm; 2016 Mar; 500(1-2):162-78. PubMed ID: 26802496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. pH-sensitive Au-BSA-DOX-FA nanocomposites for combined CT imaging and targeted drug delivery.
    Huang H; Yang DP; Liu M; Wang X; Zhang Z; Zhou G; Liu W; Cao Y; Zhang WJ; Wang X
    Int J Nanomedicine; 2017; 12():2829-2843. PubMed ID: 28435261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.